This inventor holds 7 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 5 EPO patents. Top assignees: Hospital Clinic De Barcelona, The United States of America, as Represented by the Secretary, Department of Health and Human Services, British Columbia Cancer Agency Branch. Active years: 2018-2023.
Company Filing History:
7 out of 26 
7 out of 3,690 
6 out of 66 
Years Active: 2018-2023
Title: Elaine S Jaffe: Innovator in Lymphoma Diagnosis and Treatment
Introduction:
Elaine S Jaffe, based in Great Falls, VA, is an accomplished innovator in the field of lymphoma diagnosis and treatment. With a strong background in medical research, Jaffe has made significant contributions to the understanding and management of mantle cell lymphoma (MCL) and distinguishing between different lymphoma types. Holding several patents and collaborating with renowned professionals in the field, Jaffe's work has paved the way for improved survival outcomes and personalized treatment approaches for patients.
Latest Patents:
Elaine S Jaffe's latest patents showcase her dedication to advancing the field of lymphoma diagnostics and treatment. Two notable patents include:
1. Evaluation of mantle cell lymphoma and methods related thereto: This patent introduces methods for determining a survival predictor score for individuals diagnosed with MCL. Moreover, it provides techniques for predicting survival outcomes and selecting appropriate treatments for MCL patients.
2. Method for determining lymphoma type and providing treatment: Jaffe's invention outlines a method for distinguishing between different lymphoma types based on gene expression measurements. Specifically, it focuses on differentiating between Primary Mediastinal B-cell Lymphoma (PMBCL) and Diffuse Large B-cell Lymphoma (DLBCL) and their subtypes, enabling tailored treatment options.
Career Highlights:
Throughout her career, Elaine S Jaffe has worked with esteemed organizations in the medical field, contributing significantly to lymphoma research and patient care. Some career highlights include:
1. The United States of America, as Represented by the Secretary, Department of Health and Human Services: Jaffe's affiliation with the US government highlights her involvement in impactful research initiatives for lymphoma diagnosis and treatment.
2. British Columbia Cancer Agency Branch: Jaffe's collaboration with this institution underscores her global contributions to the field, expanding beyond national boundaries to advance knowledge and patient outcomes.
Collaborations:
Elaine S Jaffe's influence extends well beyond her individual accomplishments. Collaborative efforts with renowned professionals have enriched her work and amplified its impact. Notably:
1. Louis M Staudt: Collaborating with the esteemed researcher Louis M Staudt, Jaffe's work has synergized their expertise in lymphoma biology and paved the way for cutting-edge advancements.
2. Elias Campo Guerri: Jaffe's collaboration with Elias Campo Guerri, another prominent figure in lymphoma research, has contributed to the development of innovative diagnostic and treatment approaches.
Conclusion:
Elaine S Jaffe's relentless pursuit of excellence in lymphoma diagnosis and treatment has earned her recognition as a leading innovator in the field. Through her groundbreaking patents, extensive research, and collaborations with esteemed professionals, she has significantly advanced our understanding of mantle cell lymphoma and the ability to differentiate between various lymphoma types. Jaffe's work has undoubtedly improved survival outcomes and holds promise for the future of personalized treatments for lymphoma patients globally.